Keywords: Breast, fMRI Analysis, tumor response tracking, radio-genomics, DCE-MRI
Motivation: DCE-MRI provides non-invasive insights into vascularization and the extracellular matrix, rendering it particularly suitable for assessing tumor response.
Goal(s): To identify the optimal DCE-MRI timing and texture features for predicting pathologic complete response during neoadjuvant chemotherapy in breast cancer patients.
Approach: DCE-MRI scans were taken before, early, and mid-treatment. A sample size of 488 was used for discovery and 250 for validation. Logistic regression compared predictions using benchmark FTV-based analysis and radiomics-based textures with an additional DCE-MRI scan.
Results: Mid-treatment DCE-MRI, measuring texture entropy of dependence count, is optimal for predicting pCR. This texture is uniquely linked to angiogenesis and TGF-beta signaling.
Impact: DCE-MRI effectively tracks breast tumor response by analyzing vascularization and the extracellular matrix. Specifically, mid-treatment scan measuring texture entropy of dependence count optimally predict pathologic complete response, exhibiting exclusive linkage to biological pathways such as angiogenesis and TGF-beta signaling.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords